Current Chemical Genomics and Translational Medicine

2008, 1 : 34-42
Published online 2008 February 25. DOI: 10.2174/1875397300801010034
Publisher ID: CCGTM-1-34

RESEARCH ARTICLE
 Homogenous Fluorescent Assays for Characterizing Small-Molecule Activators of AMP-Activated Protein Kinase (AMPK)

Laurie J Reichling , Steven M Riddle , Baigen Mei , Rica Bruinsma , Tony A Goossens , Kristin G Huwiler , Mark Maffitt , Alyssa M.G Newport , Xiao-Dong Qian , Carmen Ruttimann-Johnson and Kurt W Vogel, *
Invitrogen Discovery Sciences, 501 Charmany Dr, Madison, WI 53719

* Address correspondence to this author at the Invitrogen Discovery Sciences, 501 Charmany Dr, Madison, WI 53719, USA; E-mail: kurt.vogel@invitrogen.com

ABSTRACT

AMP activated protein kinase (AMPK) is a key regulator of cellular metabolism. AMPK activity is modulated in part by binding of AMP to the γ-subunit of the kinase, which increases the activity of the catalytic α-subunit. Because increased AMPK activity in the liver and in skeletal muscle leads to increased fatty acid oxidation and decreased cholesterol and fatty acid biosynthesis, activators of AMPK are being sought for treatment of type-2 diabetes and other metabolic disorders. The unique mechanism of AMPK activation offers an opportunity to develop small molecules that directly upregulate AMPK activity, and there exists a need for simplified methods to identify and characterize small-molecules that show isoform-specific effects on AMPK. We have developed a suite of fluorescence-based assays to identify and characterize such compounds, and have used these to characterize and compare activity of recombinant AMPK α1β1γ1 and α2β1γ1 isoforms in response to small molecule activators and inhibitors.